Influenza: Page 2

Seegene secures EU approval for SARS-CoV-2 assay
The clearance will allow Seegene to market the assay to small hospitals, local clinics, and public health centers for identification of COVID-19, influenza A and B, and respiratory syncytial virus (RSV).
June 28, 2022
2021 01 08 22 21 6464 Sars Co V 2 Rna 400
FDA issues EUA for Labcorp NGS test to detect SARS-CoV-2 strains
The SARS-CoV-2 virus has mutated over time, resulting in multiple strains, also known as lineages.
June 12, 2022
2021 01 11 17 03 4617 Covid Diagnostic Test Kit 400
CorDX obtains CE Mark for test for COVID-19, flu A/B, RSV
"As COVID-19 infection prevention measures relax globally, COVID and other viral infections are projected to rise," CorDx founder and CEO Jeff Yufeng Li said in a statement.
June 2, 2022
2021 01 11 17 03 4617 Covid Diagnostic Test Kit 400
Seegene unveils strategy for $12 COVID-19 PCR tests
The company's "in-life PCR" initiative includes asymptomatic testing for early virus detection and syndromic respiratory testing, as well as boosting PCR test accessibility through affordable pricing.
May 24, 2022
2021 04 27 22 24 2298 Nasal Swab Test 400
LabPulse.com Microbiology Insider
Dear Microbiology Insider,
May 17, 2022
Visby awarded $25M to develop combined flu-COVID test
The funds were awarded by the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) and will support continued development of the test. As it is, the company's Flu-COVID PCR test is a single-use, handheld, and all-in-one PCR device that detects and distinguishes between influenza A, influenza B, and SARS-CoV-2 from one sample.
March 27, 2022
2020 10 16 22 39 6807 Dollar Money Coronavirus Mask 400
Most Popular
Quest launches long-COVID testing panels for consumers
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for unnecessary urinalysis testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Quest Diagnostics offers suite of services for transplant patients and living donors
Rapid nirmatrelvir treatment in study reduced long-COVID risk
Visby raises $100M in financing
The funds will be used to scale production capacity from tens to hundreds of thousands of tests per month, to expand its product portfolio to include COVID plus influenza A/B combination testing and antimicrobial resistance panels, and to deliver PCR diagnostics to consumers at-home.
March 2, 2022
2019 08 05 19 10 8249 Dollar Sign 400
Roche adds SARS-CoV-2 tests to new Cobas 5800 systems
The expansion will see the Cobas SARS-CoV-2 Qualitative and Cobas SARS-CoV-2 and Influenza A/B tests included in the Cobas 5800 system, a recently launched molecular laboratory instrument.
February 23, 2022
2020 04 14 17 10 6379 Test Tubes Rd Lab 400
DnaNudge launches 90-minute COVID test in Australia
CovidNudge is a point-of-care test platform that consists of the DnaCartridge, a disposable and sealed lab-on-chip device, and the NudgeBox, a standalone instrument that is connected to the DnaNudge Cloud for processing.
February 15, 2022
2022 02 16 21 53 6609 Australian Flag 400
Smartphone-based LAMP assay can detect COVID, flu
Smart LAMP is portable and inexpensive to set up (less than $100, according to the authors) and consists of a hot plate, cardboard box, and LED lights. The researchers designed the diagnostic to meet five criteria for rapid and frequent testing at the point of care: speed, sensitivity, low cost, scalability, and accessibility. The assay simultaneously analyzes up to 96 saliva samples per phone at a cost of less than $7 per test, the researchers noted.
January 27, 2022
2020 03 04 00 35 9478 Smartphone Hands 400
MilliporeSigma secures $137M contract from U.S. government
The award will cover a three-year period and is from the U.S. Department of Defense, on behalf of the U.S. Department of Health and Human Services; it is part of an effort to ensure secure local supply and production capacity for critical products for pandemic preparedness, the company said in a press release.
January 3, 2022
2021 02 18 23 32 2083 Pharmaceutical Manufacturing Scientists 400
Applied BioCode receives EUA for SARS-CoV-2 combo assay
The assay can simultaneously detect and differentiate between SARS-CoV-2, influenza A with subtypes, and respiratory syncytial virus in nasopharyngeal swab specimens, the company said. The test is designed to assist physicians in evaluating patients with clinical signs and symptoms of respiratory infection.
December 16, 2021
2020 04 16 18 56 8041 Virus Coronavirus Sars Co V 2 400
Previous Page
Page 2 of 7
Next Page